This week, I attended one of my favorite events of the year...

And it's the only reason I ever go to Las Vegas.

The annual Stansberry Research Conference & Alliance Meeting was three days and nights packed with big ideas, timely market insights, and some truly outstanding speakers. I also got to meet and talk with hundreds of subscribers.

Over the course of the conference, it was clear that one topic was on everyone's mind... AI.

Here's what folks were discussing...

  • The latest innovations in AI
  • What really makes AI work
  • How AI is overhauling the economy
  • Stories of AI agents going rogue
  • How AI is taking over every aspect of our lives... from healthcare to our daily schedules

One of this week's most popular presentations on AI came from my colleague, Brett Eversole. Brett discussed what he's calling "AI Phase 2."

Over the past few years, the AI-spending boom has sent stocks like Nvidia (NVDA), Micron Technology (MU), and SpaceX (SPCX) soaring. That was "Phase 1"... and it was all about building the infrastructure needed to actually run AI – things like chips and data centers.

Now, Brett says, we're seeing a shift... Investors are now demanding that companies make the sales to back up these sky-high stock valuations. The next generation of winners will be the companies that can successfully sell AI.

The AI boom has been propping up the markets... So according to Brett, as long as the spending continues, the market boom will keep going strong. And he predicts we could potentially see several more years of this kind of AI spending.

Brett has spent 16 years developing and refining one of our firm's most data-driven research systems. And today, he has identified six investments positioned specifically for this next phase of the AI boom.

You can learn all about AI Phase 2 – including one AI stock to buy and one to sell, free of charge – in his new video briefing. Watch it here.

Now, let's get to this week's Q&A... And as always, keep sending your comments, questions, and topic suggestions to feedback@healthandwealthbulletin.com. My team and I read every e-mail.

How to Handle Vertigo

Q: My elderly mom has vertigo, and her doctor just prescribed vestibular pills. I looked them up and it seems like they could also cause problems. Can you offer any thoughts? – E.J.

A: Thanks for your question, E.J. Because there are different causes of vertigo, I can't comment on your mom's specific case. Treatment will depend on why she has it, other medications she's taking, and any additional health-related issues.

But we know that roughly a third of older Americans suffer from dizziness, formally called intermittent vertigo. Often, the problem lies in the inner ear's vestibular system, which maintains the body's balance. That could be the cause of your mom's case of vertigo.

Doctors prescribe vestibular suppressants to treat a variety of conditions... including dizziness, motion sickness, nausea, and anxiety. They lower the sensations from extreme levels.

You might assume that a medication to make you less dizzy would help you stay upright. But it turns out, when older folks regularly take vestibular suppressants, it can work too well... and interfere with their balance.

A Journal of the American Geriatrics Society study reviewed medical claims filed between 2006 and 2015 for 190,348 Americans aged 65 and over who suffered from dizziness. A third of them filled a vestibular-suppressant prescription within a month of diagnosis... most receiving antianxiety drugs (like Xanax and Valium) and 27% receiving antinausea drugs (like Dramamine and meclizine).

Within 60 days of receiving their prescriptions, 8% of these seniors had suffered a major fall that required medical attention. That's nearly 1 in every 10 people. By contrast, just 2% of the folks who didn't take any meds had a bad fall.

In general, compared with the folks who took no drugs, the seniors on antinausea medications were twice as likely to fall... and folks taking antianxiety meds were 4 times more likely to fall.

If your doctor recommends a vestibular suppressant, carefully discuss the risks and benefits. Often, dizziness and nausea can be treated without pills.

For example, this video goes through some exercises to help with dizziness. For nausea, I recommend ginger candies or ginger tea... staring at something far away on the horizon... and sitting toward the front when riding in a car, bus, plane, train, or ship.

Or do what I do for my own intermittent vertigo... If it pops up, take half a dose of a nonsedating antihistamine like loratadine.

What We're Reading...

Here's to our health, wealth, and a great retirement,

Dr. David Eifrig and the Health & Wealth Bulletin Research Team
October 2, 2026

Recent Articles

View Full Archives
Subscribe to Health & Wealth Bulletin for FREE
Get the Health & Wealth Bulletin delivered straight to your inbox.
About Health & Wealth Bulletin

Here at Health & Wealth Bulletin, our manifesto is to provide a guide for living well – at a good price and on your own terms.

We've told folks the secret to life-changing income in retirement, the exit plan that every investor needs, and the key to beating the market. And our team has been on the leading edge of reporting new discoveries like immunotherapy, the dangers of BPA, the truth about cholesterol, and more.

You see, huge corporate interests and corrupt government institutions would rather people didn't know about many of these concepts... The more ignorant the people are, the better for the government and corporate interests. This keeps folks dependent... and the "nanny state" alive. That's why we spend our days uncovering the truth and sharing it with readers.

Health & Wealth Bulletin is your free guidebook to intriguing health and wealth ideas. It's all about living the best life possible.

About the Editor
Dr. David "Doc" Eifrig
Dr. David "Doc" Eifrig
Editor

Dr. David "Doc" Eifrig has one of the most remarkable resumes of anyone we know in the finance industry. After receiving his Bachelor of Arts degree from Carleton College in Minnesota, he went on to earn a Master of Business Administration degree

from Northwestern University's Kellogg School of Management. There, he graduated on the Dean's List with a double major in finance and international business.

Doc then went to work as an elite derivatives trader at the Goldman Sachs investment bank. He spent a decade on Wall Street with several major institutions, including Chase Manhattan Bank and Yamaichi Securities (then known as the "Goldman Sachs of Japan").

That's when Doc's career took an unconventional turn. Sick of the greed and hypocrisy on Wall Street, he quit his Senior Vice President position to become a doctor. He graduated from Columbia University's postbaccalaureate premedical program and eventually earned his Medical Doctor degree with clinical honors from the University of North Carolina at Chapel Hill. While in medical school, he was elected president of his class and admitted to the Order of the Golden Fleece – the highest honor awarded at the university.

Doc also completed a research fellowship in molecular genetics at Duke University and became a board-eligible eye surgeon. Along the way, he has been published in scientific journals and helped start a small biotechnology company, Mirus Bio, which was sold to Roche for $125 million in 2008.

However, frustrated by Big Medicine's many conflicts, Doc began to look for ways to talk directly with individuals. He wanted to use his background to show them how to take control of their health and wealth. In 2008, Doc joined Stansberry Research and launched his publication, Retirement Millionaire. He has gone on to launch Retirement Trader, which uses options to help people construct safe, reliable income streams. Doc's Income Intelligence seeks out income-producing investments to maximize returns. Prosperity Investor helps investors unlock massive potential gains in health care investing. Every Monday through Friday, Doc shares his views on the latest in the financial and health industries – and tips on how to improve your own life – in Health & Wealth Bulletin.

Doc has also authored five books with four-star ratings (or better) on Amazon. In his spare time, he has run three marathons and several triathlons. He owns and produces his own wine (Eifrig Cellars) in northern Sonoma County, California. Doc is also the CEO of MarketWise, Stansberry Research's parent company.

Back to Top